P2Y-receptors mediating an inhibition of the evoked entry of calcium through N-type calcium channels at neuronal processes

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 2, 2002, Pages 520-526

  Kulick, Melanie B ^a   Von Kügelgen, Ivar ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE DIPHOSPHATE; 2 METHYLTHIOADENOSINE PHOSPHATE; 2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CADMIUM; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CHLOROMERCURIBENZENESULFONIC ACID; DIADENOSINE TETRAPHOSPHATE; FURA 2; MESSENGER RNA; N6 (2 METHYLTHIOETHYL) 2 (3,3,3 TRIFLUOROPROPYLTHIO) BETA,GAMMA DICHLOROMETHYLENE ADENOSINE 5' TRIPHOSPHATE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; OMEGA CONOTOXIN; PERTUSSIS TOXIN; PURINE P2Y RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL STRAIN; ELECTROSTIMULATION; EVOKED RESPONSE; MICROFLUOROMETRY; NERVE CELL; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE AGGREGATION;

ADENOSINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; FLUORESCENT DYES; FLUOROMETRY; FURA-2; GTP-BINDING PROTEINS; HUMANS; NEURONS; NUCLEOTIDES; PC12 CELLS; PERTUSSIS TOXIN; POLY A; PRESYNAPTIC TERMINALS; RATS; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0036828233     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037960     Document Type: Article

References (39)

1. Arslan G, Filipeanu CM, Irenius E, Kull B, Clementi E, Allgaier C, Erlinge D, and Fredholm BB (2000) P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells. Neuropharmacology 39:482-496.
2. 6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br J Pharmacol 124:1-3.
3. i. J Biol Chem 276:41479-41485.
4. Communi D, Govaerts C, Parmentier M, and Boeynaems JM (1997) Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem 272:31969-31973.
5. 2+ channel currents in cultured bovine adrenal chromaffin cells. Neuron 16:1027-1036.
6. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, et al. (2000) Nomenclature of voltage-gated calcium channels. Neuron 25:533-535.
7. Fernández-Fernández JM, Abogadie FC, Milligan G, Delmas P, and Brown DA (2001) Multiple pertussis toxin-sensitive G-proteins can couple receptors to GIRK channels in rat sympathetic neurons when expressed heterologously, but only native Gi-proteins do so in situ. Eur J Neurosci 14:283-292.
8. 2Y-like purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 348:352-357.
9. Gandia L, Garcia AG, and Morad M (1993) ATP modulation of calcium channels in chromaffin cells. J Physiol (Lond) 470:55-72.
10. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science (Wash DC) 239:57-61.
11. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, et al. (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409:202-207.
12. Inoue K, Koizumi S, Ueno S, Kita A, and Tsuda M (1999) The functions of ATP receptors in the synaptic transmission in the hippocampus. Prog Brain Res 120:193-206.
13. 2+ channels, cytoplasmic messengers and proteins of the synaptic vesicle release complex. Trends Pharmacol Sci 22:519-525.
14. Kulick M and von Kügelgen I (2001) P2Y-Receptors inhibiting electrically induced increases in intracellular calcium concentration in processes of differentiated PC-12 cells. Fundam Clin Pharmacol 15 (Suppl 1):134.
15. ADP receptor. J Neurochem 77:505-518.
16. Lambrecht G (2000) Agonists and antagonists acting at P2X receptors: Selectivity profiles and functional implications. Naunyn-Schmiedeberg's Arch Pharmacol 362:340-350.
17. 29 cells. Cell Physiol Biochem 1:273-285.
18. 2+ channels in PC12 cells. J Neurosci 16:7557-7565.
19. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 336:204-210.
20. Lukyanetz EA and Neher E (1999) Different types of calcium channels and secretion from bovine chromaffin cells. Eur J Neurosci 11:2865-2873.
21. Mintz IM, Venema VJ, Swiderek KM, Lee TD, Bean BP, and Adams ME (1992) P-type calcium channels blocked by the spider toxin omega-Aga-IVA. Nature (Lond) 355:827-829.
22. Mirotznik RR, Zheng X, and Stanley EF (2000) G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal. J Neurosci 20:7614-7621.
23. Nicholas RA, Watt WC, Lazarowski ER, Li Q, and Harden K (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective and an ATP- and UTP-specific receptor. Mol Pharmacol 50:224-229.
24. Nörenberg W and Illes P (2000) Neuronal P2X receptors: Localisation and functional properties. Naunyn-Schmiedeberg's Arch Pharmacol 362:324-339.
25. North RA and Barnard EA (1997) Nucleotide receptors. Curr Opin Neurobiol 7:346-357.
26. Powell AD, Teschemacher AG, and Seward EP (2000) P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels. J Neurosci 20:606-616.
27. 2+ in cultured sympathetic neurons. Neuroscience 52:973-986.
28. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
29. Shinozuka K, Bjur RA, and Westfall DP (1988) Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn-Schmiedeberg's Arch Pharmacol 338:221-227.
30. Silinsky EM, von Kügelgen I, Smith A, and Westfall DP (1998) Functions of extracellular nucleotides in peripheral and central neuronal tissues, in The P2 Nucleotide Receptors (Turner JT, Weisman GA, and Fedan JS eds) pp 25-290, Humana Press, Totowa, NJ.
31. 1 receptor. Mol Pharmacol 60:432-439.
32. Unterberger U, Moskvina E, Scholze T, Freissmuth M, and Boehm S (2002) Inhibition of adenylyl cyclase by neuronal P2Y receptors. Br J Pharmacol 135:673-684.
33. 2+ currents in PC12 cells. Eur J Neurosci 13:899-908.
34. 2-purinoceptors in feedback control of sympathetic transmitter release. Neuroscience 56:263-267.
35. von Kügelgen I, Nörenberg W, Koch H, Meyer A, Illes P, and Starke K (1999a) P2-Receptors controlling neurotransmitter release from postganglionic sympathetic neurones. Prog Brain Res 120:173-182.
36. von Kügelgen I, Nörenberg W, Meyer A, Illes P, and Starke K (1999b) Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 359:360-369.
37. von Kügelgen I and Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 362:310-323.
38. Yoshioka K, Saitoh O, and Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617-7622.
39. Zhang FL, Luo L, Gustafson E, Lachowicz J, Smith M, Qiao X, Liu YH, Chen G, Pramanik B, Laz TM, et al. (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276:8608-8615.